Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-6-15
pubmed:abstractText
To investigate pharmacokinetics and potency of antitumor activity of a novel 5-fluorouracil carrier erythrocyte (RBC-FU) in mice bearing malignant ascites.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1440-1746
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
985-90
pubmed:meshHeading
pubmed-meshheading:20546454-Animals, pubmed-meshheading:20546454-Antimetabolites, Antineoplastic, pubmed-meshheading:20546454-Body Weight, pubmed-meshheading:20546454-Cell Line, Tumor, pubmed-meshheading:20546454-Chromatography, High Pressure Liquid, pubmed-meshheading:20546454-Chromatography, Reverse-Phase, pubmed-meshheading:20546454-Dialysis, pubmed-meshheading:20546454-Drug Carriers, pubmed-meshheading:20546454-Drug Compounding, pubmed-meshheading:20546454-Erythrocyte Transfusion, pubmed-meshheading:20546454-Erythrocytes, pubmed-meshheading:20546454-Female, pubmed-meshheading:20546454-Fluorouracil, pubmed-meshheading:20546454-Injections, Intraperitoneal, pubmed-meshheading:20546454-Liposomes, pubmed-meshheading:20546454-Liver Neoplasms, pubmed-meshheading:20546454-Mice, pubmed-meshheading:20546454-Osmosis, pubmed-meshheading:20546454-Peritoneal Neoplasms, pubmed-meshheading:20546454-Time Factors
pubmed:year
2010
pubmed:articleTitle
Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
pubmed:affiliation
Cancer Center, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
pubmed:publicationType
Journal Article